YOLFTbeta
30

Heren Health Co Ltd

300550 · SHE · Healthcare / Health Information Services

13.33CNY-0.11 (-0.82%)

Price History

Full chart

Market Stats

Previous Close13.44
Open13.52
Day Range13.15 – 13.77
52-Week Range9.83 – 16.91
Volume4.69M
Market Cap3.63B
P/E (TTM)197.71
Forward P/E0.00
EPS0.07
Dividend Yield0.22%
Beta0.51
50-Day Avg12.55
200-Day Avg13.43

About

Heren Health Co.,Ltd. provides medical solutions to hospitals and governments in China. The company offers solutions to smart hospitals, healthy city, smart medical consortium, and medical treatment. Heren Health Co.,Ltd. was founded in 2010 and is headquartered in Hangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Chenhui Zhao
  • Employees794
  • HeadquartersNo. 625, Xinlian Road, Hangzhou, China, 310051, China
  • Websitehttps://www.herenit.com

Leadership

  • Mr. Chenhui ZhaoChairman & GM · b. 1979
  • Ms. Shuangshuang LiuFinancial Manager · b. 1986
  • Ms. Yi ZhangDeputy GM & Secretary of the Board of Directors · b. 1984
  • Shixiao FuAccounting Supervisor

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue19.30M81.48M139.83M227.18M225.13M235.64M276.26M391.42M440.96M454.74M464.20M360.33M439.25M406.01M435.06M
Growth (%)-+322.19%+71.61%+62.46%-0.90%+4.67%+17.24%+41.69%+12.66%+3.12%+2.08%-22.38%+21.90%-7.57%+7.15%
Cost of Revenue5.51M23.82M49.31M124.43M106.93M104.56M143.19M210.92M240.13M258.91M303.04M286.67M270.29M218.11M232.16M
Gross Profit----118.20M131.08M133.07M180.50M200.83M195.83M161.16M73.66M168.96M187.90M202.89M
Gross Margin----52.50%55.63%48.17%46.11%45.54%43.06%34.72%20.44%38.47%46.28%46.64%
Operating Expense----78.58M80.49M86.29M116.29M133.73M117.89M119.39M130.59M121.92M112.47M118.59M
Operating Income-12.02M30.23M39.95M39.61M50.59M46.78M64.21M67.10M77.93M41.77M-56.93M47.05M75.43M84.30M
Operating Margin-14.76%21.62%17.59%17.60%21.47%16.93%16.40%15.22%17.14%9.00%-15.80%10.71%18.58%19.38%
EBITDA------49.73M57.68M62.44M63.69M57.07M-61.26M77.49M77.15M81.27M
EBITDA Margin------18.00%14.74%14.16%14.01%12.30%-17.00%17.64%19.00%18.68%
Net Income----51.73M52.07M32.90M40.44M41.23M43.14M34.81M-83.31M39.12M39.30M47.66M
Net Income Margin----22.98%22.10%11.91%10.33%9.35%9.49%7.50%-23.12%8.91%9.68%10.96%
R&D5.60M23.32M32.63M27.57M36.87M37.18M39.70M44.68M47.36M45.72M53.83M54.05M53.81M52.52M53.10M
R&D as % of Total Revenue29.04%28.61%23.33%12.14%16.38%15.78%14.37%11.42%10.74%10.05%11.60%15.00%12.25%12.93%12.21%
Interest Expense00000002.72M5.14M2.77M2.53M3.49M3.86M4.27M2.31M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.70%1.17%0.61%0.55%0.97%0.88%1.05%0.53%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets20.60M67.78M167.59M287.77M376.71M588.99M692.92M943.82M953.08M1.56B1.52B1.43B1.44B1.46B1.50B
Total Liabilities7.24M25.25M51.25M125.28M159.32M102.66M178.40M385.99M323.08M437.29M358.90M385.71M357.91M342.42M319.51M
Total Equity12.63M42.20M116.14M162.58M214.06M479.94M504.84M547.19M618.28M1.10B1.13B1.04B1.08B1.11B1.15B
Cash6.13M32.97M73.20M75.33M76.00M128.93M117.11M365.19M299.63M440.21M455.60M506.32M555.32M542.17M532.94M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-20.43M14.73M24.97M40.71M15.88M44.68M18.23M41.42M-67.56M-17.98M-89.17M83.38M8.00M125.92M
Investing Cash Flow-----65.15M-110.27M-74.21M105.51M-162.73M-245.91M114.90M118.02M---
Financing Cash Flow980.00K10.95M35.84M23.06M32.07M149.11M17.49M118.83M-17.45M527.20M-78.03M23.38M---
Capital Expenditure3.96M5.12M12.17M55.97M35.45M45.87M38.35M17.33M17.73M63.45M76.41M37.14M24.87M45.94M41.99M
Free Cash Flow------6.32M899.02K23.68M-131.01M-94.24M-126.31M58.51M-37.95M83.92M
Dividends Paid---558.00K3.06M3.21M8.67M7.41M10.63M10.48M8.86M8.90M4.41M12.14M8.87M
FCF to OCF------14.16%4.93%57.18%193.92%524.20%141.65%70.17%-474.51%66.65%
Dividend Paid to FCF------137.14%823.92%44.91%-8.00%-9.41%-7.05%7.54%-31.98%10.57%

Earnings

Report DateDec 31, 2016Apr 26, 2017Aug 28, 2017Oct 27, 2017Feb 27, 2018Apr 26, 2018Aug 29, 2018Oct 30, 2018Dec 31, 2018Apr 26, 2019Aug 29, 2019Oct 17, 2019Feb 28, 2020Apr 27, 2020Aug 27, 2020Oct 28, 2020Dec 31, 2020Apr 26, 2021Aug 29, 2021Oct 28, 2021Dec 31, 2021Apr 27, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Aug 18, 2023Oct 23, 2023Feb 2, 2024Apr 24, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 15, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------
EPS Actual0.080.010.050.040.060.010.050.050.070.030.070.060.030.010.030.080.070.030.050.06-0.000.020.050.02-0.410.00-0.010.060.10-0.00-0.050.060.15-0.010.000.060.13-0.04-0.09
Surprise---------------------------------------
Timing-After-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market-After-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-Pre-market----After-hoursPre-marketAfter-hoursPre-market---After-hours-----

Key Statistics & Ratios

Market Cap3.63B
Enterprise Value3.33B
Trailing P/E197.71
Forward P/E0.00
Price / Sales8.38
Price / Book3.40
EPS0.07
Book Value4.24
Revenue (TTM)433.88M
Gross Profit (TTM)179.81M
EBITDA24.75M
Profit Margin4.51%
Operating Margin-37.39%
Return on Equity2.09%
Return on Assets0.90%
Shares Outstanding262.56M
Shares Float145.78M
Beta0.51
Dividend Yield0.22%
Dividend Rate0.03
Payout Ratio40.27%

Dividends

20261×
0.03Jun 15, 2026
20251×
0.03Jun 30, 2025
20241×
0.03Jun 25, 2024
20221×
0.02Jul 7, 2022
20211×
0.03Jun 16, 2021
20201×
0.04Jun 17, 2020
20191×
0.03Jun 17, 2019
20181×
0.02Jun 12, 2018
20171×
0.04Jun 22, 2017

Stock Splits

  • Jun 16, 20211.4:1
  • Jun 17, 20201.4:1
  • Jun 17, 20191.4:1